Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.
Cheuk-Chun SzetoKentaro SuganoJi-Guang WangKazuma FujimotoSamuel WhittleGopesh K ModiChen-Huen ChenJeong-Bae ParkLai-Shan TamKriengsak VareesangthipKelvin Kam-Fai TsoiFrancis Ka Leung ChanPublished in: Gut (2020)
NSAIDs are a valuable armamentarium in clinical medicine, but appropriate recognition of high-risk cases, selection of a specific agent, choice of ulcer prophylaxis and monitoring after therapy are necessary to minimise the risk of adverse events.